Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study

被引:104
作者
Falcone, Marco [1 ]
Tiseo, Giusy [1 ]
Giordano, Cesira [2 ]
Leonildi, Alessandro [1 ]
Menichini, Melissa [2 ]
Vecchione, Alessandra [2 ]
Pistello, Mauro [3 ,4 ]
Guarracino, Fabio [5 ]
Ghiadoni, Lorenzo [6 ]
Forfori, Francesco [7 ]
Barnini, Simona [2 ]
Menichetti, Francesco [1 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Infect Dis Unit, Pisa, Italy
[2] Azienda Osped Univ Pisana, Microbiol Unit, Pisa, Italy
[3] Univ Pisa, Virol Unit, Dept Lab Med, Pisa Univ Hosp, Pisa, Italy
[4] Univ Pisa, Retrovirus Ctr, Dept Translat Res, Pisa, Italy
[5] Azienda Osped Univ Pisana, Dept Anaesthesia & Crit Care Med, Pisa, Italy
[6] Univ Pisa, Dept Clin & Expt Med, Emergency Med Unit, Pisa, Italy
[7] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Care Med, Pisa, Italy
关键词
D O I
10.1093/jac/dkaa530
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Bacterial and fungal superinfections may complicate the course of hospitalized patients with COVID-19. Objectives: To identify predictors of superinfections in COVID-19. Methods: Prospective, observational study including patients with COVID-19 consecutively admitted to the University Hospital of Pisa, Italy, between 4 March and 30 April 2020. Clinical data and outcomes were registered. Superinfection was defined as a bacterial or fungal infection that occurred >= 48 h after hospital admission. A multivariate analysis was performed to identify factors independently associated with superinfections. Results: Overall, 315 patients with COVID-19 were hospitalized and 109 episodes of superinfections were documented in 69 (21.9%) patients. The median time from admission to superinfection was 19 days (range 11-29.75). Superinfections were caused by Enterobacterales (44.9%), non-fermenting Gram-negative bacilli (15.6%), Gram-positive bacteria (15.6%) and fungi (5.5%). Polymicrobial infections accounted for 18.3%. Predictors of superinfections were: intestinal colonization by carbapenem-resistant Enterobacterales (OR 16.03, 95% CI 6.5-39.5, P< 0.001); invasive mechanical ventilation (OR 5.6, 95% CI 2.4-13.1, P< 0.001); immunomodulatory agents (tocilizumab/baricitinib) (OR 5.09, 95% CI 2.2-11.8, P< 0.001); C-reactive protein on admission >7 mg/dl (OR 3.59, 95% CI 1.7-7.7, P= 0.001); and previous treatment with piperacillin/tazobactam (OR 2.85, 95% CI 1.1-7.2, P= 0.028). Length of hospital stay was Longer in patients who developed superinfections ompared with those who did not (30 versus 11 days, P< 0.001), while mortality rates were similar (18.8% versus 23.2%, P= 0.445). Conclusions: The risk of bacterial and fungal superinfections in COVID-19 is consistent. Patients who need empiric broad-spectrum antibiotics and immunomodulant drugs should be carefully selected. Infection control rules must be reinforced.
引用
收藏
页码:1078 / 1084
页数:7
相关论文
共 22 条
  • [1] Bartoletti M, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1065, DOI 10.1093/CID/CIAA1065]
  • [2] SARS-CoV-2, bacterial co-infections, andAMR: the deadly trio inCOVID-19?
    Bengoechea, Jose A.
    Bamford, Connor G. G.
    [J]. EMBO MOLECULAR MEDICINE, 2020, 12 (07)
  • [3] Antibiotic use in patients with COVID-19: a 'snapshot' Infectious Diseases International Research Initiative (ID-IRI) survey
    Beovic, Bojana
    Dousak, May
    Ferreira-Coimbra, Joao
    Nadrah, Kristina
    Rubulotta, Francesca
    Belliato, Mirko
    Berger-Estilita, Joana
    Ayoade, Folusakin
    Rello, Jordi
    Erdem, Hakan
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (11) : 3386 - 3390
  • [4] Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Validation of Scores and Proposal for Management
    Cano, Angela
    Gutierrez-Gutierrez, Belen
    Machuca, Isabel
    Gracia-Ahufinger, Irene
    Perez-Nadales, Elena
    Causse, Manuel
    Jose Caston, Juan
    Guzman-Puche, Julia
    Torre-Gimenez, Julian
    Kindelan, Lara
    Martinez-Martinez, Luis
    Rodriguez-Bano, Jesus
    Torre-Cisneros, Julian
    [J]. CLINICAL INFECTIOUS DISEASES, 2018, 66 (08) : 1204 - 1210
  • [5] Centers for Disease Control and Prevention (CDC), CDC/NHSN Surveillance Definitions for Specific Types of Infections
  • [6] Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study
    Falcone, Marco
    Tiseo, Giusy
    Barbieri, Greta
    Galfo, Valentina
    Russo, Alessandro
    Virdis, Agostino
    Forfori, Francesco
    Corradi, Francesco
    Guarracino, Fabio
    Carrozzi, Laura
    Celi, Alessandro
    Santini, Massimo
    Monzani, Fabio
    De Marco, Salvatore
    Pistello, Mauro
    Danesi, Romano
    Ghiadoni, Lorenzo
    Farcomeni, Alessio
    Menichetti, Francesco
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (12):
  • [7] Cefiderocol as Rescue Therapy for Acinetobacter baumannii and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients
    Falcone, Marco
    Tiseo, Giusy
    Nicastro, Manuela
    Leonildi, Alessandro
    Vecchione, Alessandra
    Casella, Costanza
    Forfori, Francesco
    Malacarne, Paolo
    Guarracino, Fabio
    Barnini, Simona
    Menichetti, Francesco
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) : 2021 - 2024
  • [8] Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales
    Falcone, Marco
    Daikos, George L.
    Tiseo, Giusy
    Bassoulis, Dimitrios
    Giordano, Cesira
    Galfo, Valentina
    Leonildi, Alessandro
    Tagliaferri, Enrico
    Barnini, Simona
    Sani, Spartaco
    Farcomeni, Alessio
    Ghiadoni, Lorenzo
    Menichetti, Francesco
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) : 1871 - 1878
  • [9] Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing Enterobacterales During a Regional Outbreak
    Falcone, Marco
    Tiseo, Giusy
    Antonelli, Alberto
    Giordano, Cesira
    Di Pilato, Vincenzo
    Bertolucci, Pietro
    Parisio, Eva Maria
    Leonildi, Alessandro
    Aiezza, Noemi
    Baccani, Ilaria
    Tagliaferri, Enrico
    Righi, Lorenzo
    Forni, Silvia
    Sani, Spartaco
    Mechi, Maria Teresa
    Pieralli, Filippo
    Barnini, Simona
    Rossolini, Gian Maria
    Menichetti, Francesco
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (02):
  • [10] Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae
    Falcone, Marco
    Bassetti, Matteo
    Tiseo, Giusy
    Giordano, Cesira
    Nencini, Elia
    Russo, Alessandro
    Graziano, Elena
    Tagliaferri, Enrico
    Leonildi, Alessandro
    Barnini, Simona
    Farcomeni, Alessio
    Menichetti, Francesco
    [J]. CRITICAL CARE, 2020, 24 (01)